ArticleResearch square2025
Deep Proteomic Profiling of Human Stem Cell-Derived Microglia: Insights Into Inflammatory and Alcohol-Induced Reactivity.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Alcohol use disorder (AUD) is associated with significant neuroimmune dysregulation, with microglia emerging as a potential pathological driver of neurotoxicity. However, the molecular landscape driving this alcohol-induced reactivity has yet to be uncovered, especially in the context of human microglia. Here, we comprehensively characterized global-scale molecular changes of human stem cell-derived microglia (iMGLs) after exposure to ethanol and inflammatory mediators lipopolysaccharide (LPS) and TNFα using mass spectrometry-based proteomics. KOLF2.1J hiPSCs were differentiated to iMGLs utilizing commercially available kits and treated with multiple ethanol exposure paradigms, LPS, and TNFα. Proteomic profiles were assessed by data-independent acquisition (DIA) mass spectrometry, followed by a Luminex cytokine assay and a functional phagocytosis assay. Ethanol produced distinct, temporally dependent proteomic changes that differed markedly from the robust proinflammatory responses induced by LPS and TNFα. Cytokine measurement confirmed an overall lack of proinflammatory responses of iMGLs treated with ethanol in contrast to the elevated levels in LPS- and TNFα-treated cells. However, Ingenuity Pathway Analysis and flow cytometry revealed an increase in phagocytosis of iMGLs treated with ethanol for 48 hours. Our findings demonstrate that ethanol exposure induces distinct and temporally dependent molecular phenotypes in human iMGLs, which differ markedly from the robust proinflammatory responses elicited by LPS and TNFα. The novel pathways identified in this study will provide new insights into the human-specific response to ethanol and emphasizes the importance of utilizing human-specific models for neuroimmune interactions in AUD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.